Quantum Simulation Technologies Inc.

Funding and NIH signals

• NIH award NIH awarded $1.02M (SBIR Phase II 2R44GM152994-02, competing renewal, notice Sep 1, 2026). NIH RePORTER 2R44GM152994-02 (Sep 1, 2026)
  Evidence (1 event)

  • Sep 1, 2026 · NIH RePORTER 2R44GM152994-02
    Organization: QUANTUM SIMULATION TECHNOLOGIES, INC.; City/State: Boston, MA; Project number: 2R44GM152994-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-01; FY total cost (award amount): 1022908; Administering IC: National Institute of General Medical Sciences; Project title: Binding free energy predictions for peptide drugs: A novel machine learning-based peptide simulation model for high-throughput computational lead optimization with quantum mechanical accuracy.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals